(Q35967215)

11 August 2017

1 reference

title

Management of hyperuricemia with rasburicase review (English)

1 reference

11 August 2017

de Bont JM

1

1 reference

11 August 2017

Pieters R

series ordinal

2

1 reference

11 August 2017

publication date

1 October 2004

1 reference

Nucleosides, Nucleotides & Nucleic Acids

11 August 2017

published in

1 reference

11 August 2017

volume

23

1 reference

11 August 2017

issue

8-9

1 reference

11 August 2017

page(s)

1431-1440

1 reference

https://api.crossref.org/works/10.1081%2FNCN-200027656

11 August 2017

1 reference

Elitek-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-200027656

European experience in the treatment of hyperuricemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-200027656

Rasburicase: an innovative new treatment for hyperuricemia associated with tumor lysis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-200027656

Rasburicase: a potent uricolytic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-200027656

Urate oxidase in the prophylaxis or treatment of hyperuricemia: the United States experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-200027656

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-200027656

Modification of a reactive cysteine explains differences between rasburicase and Uricozyme, a natural Aspergillus flavus uricase

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-200027656

Advances in the management of malignancy-associated hyperuricaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-200027656

Recombinant urate oxidase (rasburicase) in the prevention and treatment of malignancy-associated hyperuricemia in pediatric and adult patients: results of a compassionate-use trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-200027656

A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-200027656

21 January 2018

Identifiers

DOI

10.1081/NCN-200027656

1 reference

11 August 2017

1 reference